Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias (ZFOVA)
Multi-center, Randomized, Controlled, Prospective Trial to Compare the Feasibility, Safety, and Efficacy of Zero-fluoroscopic Ablation Versus Conventional Fluoroscopic Ablation for the Treatment of Ventricular Arrhythmias.
Sponsor: Fu Wai Hospital, Beijing, China
Listed as NCT03041519, this NA trial focuses on Ventricular Arrythmia and Ventricular Premature Complexes and remains ongoing. Sponsored by Fu Wai Hospital, Beijing, China, it has been updated 6 times since 2011, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown NA
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status NA
-
Feb 2019 — Jan 2021 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jun 2018 — Feb 2019 [monthly]
Recruiting NA
▶ Show 1 earlier version
-
Feb 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
Oct 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fu Wai Hospital, Beijing, China
- Guangxi Medical University
- Ningbo No. 1 Hospital
- Shanghai Tongji Hospital, Tongji University School of Medicine
- Tongji Hospital
- Xinyang Central Hospital
For direct contact, visit the study record on ClinicalTrials.gov .